AmandaBrooks(Peel)KaganMD

PubMed

• 3 citations
  DNA methyltransferase inhibitor exposure-response: Challenges and opportunities.
  Amanda B Kagan, Dominique A Garrison, Nicole M Anders, Jonathan A Webster, Sharyn D Baker, Srinivasan Yegnasubramanian, Michelle A Rudek> ;Clinical and Translational Science. 2023 Aug 1
• ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative.
  Amanda B Kagan, Blake S Moses, Rena Lapidus, Bryan T Mott, Ganesha Rai, Nicole M Anders, Stephen W Hoag, Michelle A Rudek, Curt I Civin> ;Cancer Chemotherapy and Pharmacology. 2023 Jul 1
• 4 citations
  Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies.
  Danielle Shafer, Amanda B Kagan, Michelle A Rudek, Maciej Kmieciak, Mary Beth Tombes, Ellen Shrader, Dipankar Bandyopadhyay, Daniel Hudson, Heidi Sankala, Caryn Weir, ...> ;Cancer Chemotherapy and Pharmacology. 2023 Mar 1
• 2 citations
  Trainee-Led Quality Improvement Project to Improve Fertility Preservation Counseling for Patients With Cancer.
  Laura A. Sena, Ramy Sedhom, Susan C. Scott, Amanda Kagan, Andrew H. Marple, Jenna Van Liere Canzoniero, Melinda Hsu, Syed Mohammed Qasim Hussaini, Amin S. Herati, Laur...> ;JCO Oncology Practice. 2021 Sep 25
• 4 citations
  A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable Pharmacology.
  Amanda B Kagan, Blake S Moses, Bryan T Mott, Ganesha Rai, Nicole M Anders, Michelle A Rudek, Curt I Civin> ;Frontiers in Oncology. 2021 Jan 1
• Join now to see all